Wolfe Laboratories To Perform GLP Laboratory Services For The Pharmaceutical And Biotech Industries

Wolfe Laboratories, Inc. (WLI), a contract research and development company, announces the introduction of Good Laboratory Practices (GLP) compliant testing services for pharmaceutical and biotechnology companies. WLI has implemented a quality program to support GLP laboratory services offerings. This is the latest step in continuing to grow the depth and breadth of services to WLI's clients.

"We are very excited about a new direction that Wolfe Laboratories is taking. Our focus on client relations has always been very strong and offering extensive services to our clients is the way to bring the relationship to a different level," says Janet Wolfe, Ph.D., President of WLI. The company facilitates the progression of pre-clinical programs by becoming highly involved during the stages of early discovery and development. The new GLP service line will build upon the established bioanalytical and formulation groups to continue to deliver high quality, reliable and consistent results.

The addition of GLP services is the latest of several recent developments at the Watertown-based pharmaceutical development laboratory. WLI recently tripled the space in its state-of-the-art laboratories to accommodate for new services and future growth. Expanding services to GLP compliance offers an accelerated and cost-effective approach to clients who are preparing compounds for clinical trials. WLI expects increased client referral and service demand in response to these developments.

About Wolfe Laboratories, Inc.
WLI offers a variety of pre-clinical services, including pre-formulation and formulation development, analytical method development and characterization, PK and in vitro ADME bioanalytical development, dose formulation stability and uniformity assessment, and lyophilization services. For more information, visit www.wolfelabs.com.

SOURCE: Wolfe Laboratories, Inc.